SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates BHVN, VIVO, HNGR, CMAX

NEW YORK, Aug. 15, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN)'s sale to Pfizer Inc. for $148.50 per share in cash. Biohaven common shareholders, including Pfizer, will also receive 0.5 of a share of New Biohaven, a new publicly traded company that will retain Biohaven's non-CGRP development stage pipeline compounds, per Biohaven common share. If you are a Biohaven shareholder, click here to learn more about your rights and options.  

Meridian Bioscience, Inc. (NASDAQ: VIVO)'s sale to SD Biosensor, Inc. and SJL Partners LLC for $34.00 per share in cash. If you are a Meridian shareholder, click here to learn more about your rights and options.

Hanger, Inc. (NYSE: HNGR)'s sale to Patient Square Capital for $18.75 in cash per share. If you are a Hanger shareholder, click here to learn more about your rights and options.

CareMax, Inc. (NASDAQ: CMAX)'s merger with Steward Health Care System. If you are a CareMax shareholder, click here to learn more about your rights and options.  

Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected] 
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP